Dr. Peter Zandstra
Today’s announcement that the federal government will invest $114 million over seven years in the University of Toronto’s “Medicine by Design” research initiative comes as exciting news to every Canadian excited about the potential of regenerative medicine to save lives.…
Today’s announcement that the federal government will invest $114 million over seven years in the University of Toronto’s “Medicine by Design” research initiative comes as exciting news to every Canadian excited about the potential of regenerative medicine to save lives.
This is a significant momentum-builder for the field,” says James Price, President and CEO of the Canadian Stem Cell Foundation. “It is great to see our country developing the assets it needs to make it increasingly possible to implement the Canadian Stem Cell Strategy & Action Plan.”
The Foundation supported the grant application – part of the federal government’s $1.5-billion Canada First Research Excellence Fund for universities and colleges – when the bid was submitted last winter. The Honourable Ed Holder, Minister of State (Science and Technology) made the announcement in Toronto.
“Stem cells offer avenues to treat – and perhaps cure – devastating and costly illnesses such as cardiovascular disease, diabetes, blindness, lung disease, neurodegenerative disorders, and diseases of the blood and musculoskeletal system,” Dr. Peter Zandstra, a Medicine by Design leader and member of the Foundation’s Science Leadership Council, says in the Government of Canada’s press release.
The Strategy & Action Plan, developed by a coalition of researchers, medical professionals, health charities, industry leaders and philanthropists, sets the course for Canada to lead the way in delivering up to 10 new curative therapies within 10 years. The Ontario Institute for Cancer Research and the Centre for Commercialization of Regenerative Medicine, both partners in the Medicine by Design initiative, played key roles in developing the Strategy.
Mr. Price calls Medicine by Design an important research-focused step toward building a vibrant regenerative medicine ecosystem that can deliver new therapies to the clinic. “We look forward to working with the University of Toronto on this important project.”